ACADIA Pharmaceuticals Inc.
ACAD
$20.87
$0.150.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.92% | 5.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.92% | 5.32% | |||
| Cost of Revenue | 1.38% | 10.93% | |||
| Gross Profit | 2.28% | 1.97% | |||
| SG&A Expenses | 16.65% | -0.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.77% | 4.60% | |||
| Operating Income | -51.36% | 10.45% | |||
| Income Before Tax | -40.98% | 10.90% | |||
| Income Tax Expenses | -809.54% | -300.69% | |||
| Earnings from Continuing Operations | 281.13% | 169.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 281.13% | 169.18% | |||
| EBIT | -51.36% | 10.45% | |||
| EBITDA | -47.51% | 9.62% | |||
| EPS Basic | 280.03% | 167.53% | |||
| Normalized Basic EPS | -41.19% | 10.29% | |||
| EPS Diluted | 280.83% | 164.32% | |||
| Normalized Diluted EPS | -41.21% | 9.60% | |||
| Average Basic Shares Outstanding | 0.30% | 0.60% | |||
| Average Diluted Shares Outstanding | 0.42% | 1.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||